心房颤动与心力衰竭双重流行的治疗考量
Treatment Considerations for a Dual Epidemic of Atrial Fibrillation and Heart Failure.
作者信息
Sharma Parikshit S, Callans David J
机构信息
Dr. Sharma- Cardiology Fellow, Wright Center for Graduate Medical Education, Scranton, PA; Associate Professor of Medicine, The Commonwealth Medical College, Scranton, PA.Dr. Callans- Professor of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA.
出版信息
J Atr Fibrillation. 2013 Aug 31;6(2):740. doi: 10.4022/jafib.740. eCollection 2013 Aug-Sep.
Abstract
Atrial fibrillation (AF) and heart failure (HF) have emerged as major cardiovascular epidemics in developed nations over the past decade. They share similar risk factors, seem to mutually accelerate progression and are associated with increased morbidity and mortality. Their relationship involves complex hemodynamic, neuro-hormonal, inflammatory and electrophysiologic mechanisms, which go beyond just mutual risk factors. This review focuses on updates in AF and HF with a hope of better understanding this relationship and the management of this complex duo.
摘要
在过去十年中，心房颤动（AF）和心力衰竭（HF）已成为发达国家主要的心血管流行病。它们具有相似的危险因素，似乎相互加速病情进展，且与发病率和死亡率增加相关。它们之间的关系涉及复杂的血流动力学、神经激素、炎症和电生理机制，这不仅仅是共同的危险因素。本综述重点关注心房颤动和心力衰竭的最新进展，以期更好地理解这种关系以及对这一复杂组合的管理。
相似文献
1
Treatment Considerations for a Dual Epidemic of Atrial Fibrillation and Heart Failure.
J Atr Fibrillation. 2013 Aug 31;6(2):740. doi: 10.4022/jafib.740. eCollection 2013 Aug-Sep.
2
Left Atrial Appendage Thrombus Despite Anticoagulation.
J Atr Fibrillation. 2013 Jun 30;6(1):865. doi: 10.4022/jafib.865. eCollection 2013 Jun-Jul.
3
Management strategies in atrial fibrillation in patients with heart failure.
Cardiol Rev. 2012 Nov-Dec;20(6):288-96. doi: 10.1097/CRD.0b013e31825dcf9b.
4
Atrial fibrillation in heart failure in the older population.
Heart Fail Clin. 2013 Oct;9(4):451-9, viii-ix. doi: 10.1016/j.hfc.2013.07.007.
5
Atrial fibrillation in heart failure: a comprehensive review.
Am J Med. 2010 Mar;123(3):198-204. doi: 10.1016/j.amjmed.2009.06.033.
6
Heart failure progression and mortality in atrial fibrillation patients with preserved or reduced left ventricular ejection fraction.
J Interv Card Electrophysiol. 2019 Sep;55(3):325-331. doi: 10.1007/s10840-019-00534-x. Epub 2019 Mar 18.
7
Epidemiology of Atrial Fibrillation and Heart Failure: A Growing and Important Problem.
Cardiol Clin. 2019 May;37(2):119-129. doi: 10.1016/j.ccl.2019.01.001. Epub 2019 Feb 22.
8
Type of Atrial Fibrillation and Outcomes in Patients With Heart Failure and Reduced Ejection Fraction.
J Am Coll Cardiol. 2017 Nov 14;70(20):2490-2500. doi: 10.1016/j.jacc.2017.09.027.
9
Electrical treatment of atrial arrhythmias in heart failure patients implanted with a dual defibrillator CRT device. Results from the TRADE-HF study.
Int J Cardiol. 2017 Jun 1;236:181-186. doi: 10.1016/j.ijcard.2017.01.101. Epub 2017 Jan 19.
10
Predictors and prognostic implications of incident heart failure following the first diagnosis of atrial fibrillation in patients with structurally normal hearts: the Belgrade Atrial Fibrillation Study.
Eur J Heart Fail. 2013 Apr;15(4):415-24. doi: 10.1093/eurjhf/hft004. Epub 2013 Jan 9.
引用本文的文献
1
Metabolomics in Atrial Fibrillation: Unlocking Novel Biomarkers and Pathways for Diagnosis, Prognosis, and Personalized Treatment.
J Clin Med. 2024 Dec 25;14(1):34. doi: 10.3390/jcm14010034.
2
Intermedin 1-53 Ameliorates Atrial Fibrosis and Reduces Inducibility of Atrial Fibrillation via TGF-β1/pSmad3 and Nox4 Pathway in a Rat Model of Heart Failure.
J Clin Med. 2023 Feb 15;12(4):1537. doi: 10.3390/jcm12041537.
3
Metabolomics of the tryptophan-kynurenine degradation pathway and risk of atrial fibrillation and heart failure: potential modification effect of Mediterranean diet.
Am J Clin Nutr. 2021 Nov 8;114(5):1646-1654. doi: 10.1093/ajcn/nqab238.
4
The Predictive Value of Tissue Doppler Indices for Early Recurrence of Atrial Fibrillation After Electrical Cardioversion.
Clin Interv Aging. 2020 Oct 7;15:1917-1925. doi: 10.2147/CIA.S263303. eCollection 2020.
本文引用的文献
1
Incidence and prevalence of atrial fibrillation and associated mortality among Medicare beneficiaries, 1993-2007.
Circ Cardiovasc Qual Outcomes. 2012 Jan;5(1):85-93. doi: 10.1161/CIRCOUTCOMES.111.962688. Epub 2012 Jan 10.
2
Executive summary: heart disease and stroke statistics--2012 update: a report from the American Heart Association.
Circulation. 2012 Jan 3;125(1):188-97. doi: 10.1161/CIR.0b013e3182456d46.
3
Dronedarone in high-risk permanent atrial fibrillation.
N Engl J Med. 2011 Dec 15;365(24):2268-76. doi: 10.1056/NEJMoa1109867. Epub 2011 Nov 14.
4
Atrial fibrillation and mortality in heart failure: a community study.
Circ Heart Fail. 2011 Nov;4(6):740-6. doi: 10.1161/CIRCHEARTFAILURE.111.962688. Epub 2011 Sep 15.
5
Atrial fibrillation and heart failure parallels: lessons for atrial fibrillation prevention.
Crit Pathw Cardiol. 2011 Mar;10(1):46-51. doi: 10.1097/HPC.0b013e31820e1a4b.
6
Prevention of atrial fibrillation with omega-3 fatty acids: a meta-analysis of randomised clinical trials.
Heart. 2011 Jul;97(13):1034-40. doi: 10.1136/hrt.2010.215350. Epub 2011 Apr 8.
7
Effect of statins on atrial fibrillation: collaborative meta-analysis of published and unpublished evidence from randomised controlled trials.
BMJ. 2011 Mar 16;342:d1250. doi: 10.1136/bmj.d1250.
8
Irbesartan in patients with atrial fibrillation.
N Engl J Med. 2011 Mar 10;364(10):928-38. doi: 10.1056/NEJMoa1008816.
9
Outcomes of cardiac resynchronization therapy in patients with versus those without atrial fibrillation: a systematic review and meta-analysis.
Heart Rhythm. 2011 Jul;8(7):1088-94. doi: 10.1016/j.hrthm.2011.02.014. Epub 2011 Feb 19.
10
Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association.
Circulation. 2011 Mar 1;123(8):933-44. doi: 10.1161/CIR.0b013e31820a55f5. Epub 2011 Jan 24.
Zotero 插件